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Abstract
Background: Some adult stem cells persist in adult tissue; however, we do not know how to stimulate stem cells
in adults to heal injuries. Liver growth factor (LGF) is a biliprotein with hepatic mitogen activity. Its concentration
increases markedly in the presence of any type of liver injury, and it shows in vivo therapeutic biological activity at
extrahepatic sites.
Methods: We have analyzed the effect of LGF on the replenishment of germinal cells in the testes of mice
injected with busulfan, a common cancer drug that also specifically affects germ line stem cells and
spermatogonia. We determined the testicular and epididymal weight, spermatozoal concentration in the
epididymis and sperm motility, and performed a histological analysis.
Results: Intraperitoneal administration of LGF was able to partially restore spermatogenesis, as well as sperm
production and motility, in mice sterilized with busulfan. LGF treatment in busulfan-treated animals that have
suffered a disruption of spermatogenesis can accelerate the reactivation of this process in most of the tubules, as
shown in the histological analysis.
Conclusions: Our results suggest a potential use of LGF in the mobilization of testicular stem cells and in the
restoration of spermatogenesis after busulfan-induced damage to the testicular germinal epithelium.
Background
Liver growth factor (LGF) is an albumin-bilirubin com-
plex purified from both rat serum and from patients with
hepatobiliary disorders [1]. It has been demonstrated that
LGF stimulates cell proliferation with no signs of toxicity
or tissue degeneration [2]. LGF is used in some experi-
mental models of hypertension, fibrotic lung disease and
Parkinson’s disease, showing its potential as an antifibro-
tic, antihypertensive and neuroregenerative agent [3-5]. It
has been proposed to be a novel factor useful for neuro-
nal replacement in neurodegenerative diseases [3]. Few
experiments have been carried out to study the role of
LGF in testicular regeneration [6]. That study, performed
in the rat model, concluded that LGF seems to stimulate
testicular regeneration after ethane dimethanesulfonate
(EDS)-induced Leydig cell depletion. It prevents the germ
cell sloughing and Sertoli cell damage and promotes
germinal cell growth. Moreover, LGF stimulates the
synthesis of vascular endothelial growth factor (VEGF)
and its receptors in testis [7]. In the testis, it may be
related to spermatogenesis and Leydig cell physiology,
since there is no active angiogenesis in the adult male.
In order to carry out the functional assessment of the
role of LGF in the renewal activity of male germ line
stem cells, cytotoxic testicular damage was induced in
mice by intraperitoneal administration of busulfan.
Busulfan is an alkylating agent that adversely affects
spermatogenesis in mammals, and it is the drug of
choice in the treatment of chronic myelogenous or
granulocytic leukemia [8] because its cytotoxic activity
results in primary destruction of hematopoietic cells.
Nevertheless, some secondary malignancies, such as
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infertility being the major long-term effect of che-
motherapy in males. Many authors have used busulfan
to deplete stem cells [10-12]. Unlike other chemicals
that destroy differentiated spermatogonia, busulfan is a
potent agent that preferentially kills spermatogonial
stem cells of several species [13]. It has no effect on
DNA synthesis; however, it inhibits the next mitosis
when it intoxicates the cells in the G1 phase [12]. High-
dose administration of busulfan (40 mg/kg) eliminates
germ cells, sterilizes males and causes long-term mor-
phological damage to sperm produced by surviving stem
spermatogonia [10,14]. However, other authors have
shown that after the administration of a single dose of
busulfan, partial recovery of spermatogenesis can take
place after two spermatic cycles [15].
In this work, we have studied the effects of the admin-
istration of LGF on testicular regeneration in mice pre-
viously treated with busulfan.
Methods
Experimental groups and treatments
Mature male CD1 mice (3-4 months of age) were divided
into the following groups: untreated controls (n = 10);
busulfan, administered intraperitoneally (i.p.) (40 mg/kg
body weight per dose, two doses at a one-week interval;
n = 10); LGF alone, at 1.7 μg/mouse, i.p. (animals were
injected twice a week for 2 weeks; n = 15); and busulfan
+LGF (same doses as previous groups; n = 18). Mice
were kept on a 14L:10 D light cycle. All animal experi-
ments were performed in accordance with the Internal
Institutional Animal Care and Use Committee of the
Instituto Nacional de Investigación y Tecnología Agraria
y Alimentaria (Madrid, Spain). Busulfan (Sigma, St.
Louis, MO) was first dissolved in dimethyl sulfoxide
(Sigma), after which, an equal volume of sterile distilled
water was added to provide the final concentration of
4 0m g / k g .T h ef o u rg r o u p so fm a l ea n i m a l sw e r ea n a -
lyzed in two independent experiments.
LGF purification
LGF preparations were lyophilized and stored at 4 -C until
used, at which time, aliquots were dissolved in saline for
i.p. injection. Before using LGF in these experiments, we
checked its activity in vivo at several doses, injecting it
into normal rats to establish the dose that produced the
greatest stimulation of liver DNA synthesis, as determined
by incorporation of 3H-thymidine (New England Nuclear,
Dreiech, Germany) into DNA [16]. LGF was quantified by
high-performance liquid chromatography [17,18].
LGF administration
Two doses of 1.7 μg/LGF/mouse were injected i.p. each
week for two consecutive weeks; the LGF injections
were administered 1 week after the first busulfan injec-
tion. Animals were sacrificed by cervical dislocation
63 days after the administration of busulfan. Body
weight and testicular and epididymal weight were mea-
sured for each male, and sperm concentration and moti-
lity were evaluated.
Histological study
Left testes were prepared by making an incision from the
proximal to the distal pole, and fragments of parenchyma
were fixed in formalin for 24 h. The immersion-fixed
testes were sliced transversely into approximately 3-mm
thick strips and processed for paraffin embedding. Sec-
tions (5-μm thick) across the seminiferous tubules were
deparaffinised, hydrated and stained with hematoxylin
and eosin for histological examination. The diameters of
30 randomly selected transverse sections of the round-
shaped seminiferous tubules were measured for each
animal across the minor axis of their cross-sectioned
profiles [19].
Sperm characteristics
Sperm counts were performed using a Burker haemocyt-
ometer. Motility was determined by loading a sperm
sample onto a prewarmed (37°C) slide and placing it on
the heated (37°C) microscope stage [20]. Percentages of
motile spermatozoa were assessed by the Integrated
Semen Analysis System (ISAS) (Projectes i Serveis R+D
S.L., Valencia, Spain).
Sperm viability
Percentages of live and dead sperm cells were deter-
mined using a live-cell nucleic acid stain, SYBR-14, in
combination with the conventional dead-cell nucleic
acid stain, propidium iodide [21], according to the stain-
ing protocol of the live/dead sperm viability kit (Mole-
c u l a rP r o b e s ,E u g e n e ,O R ) .B r i e f l y ,0 . 8μlo f2 0m M
SYBR-14 working solution and 1.2 μlo f2 . 4m Mp r o p i -
dium iodide working solution were added to 50 μlo f
the sperm suspension (2-3 × 10
6 sperm cells/ml) and
incubated at 37°C for 15 min. Then, 20 μl of the sperm
suspension were loaded on a glass slide, covered with a
cover slip, and immediately observed under a fluores-
cent microscope equipped with appropriate filters.
SYBR-14 stains the nucleus of live sperm green, while
dead or membrane-damaged spermatozoa are stained
red by the propidium iodide. At least 500 cells were
counted per treatment.
Statistical analysis
Statistical analyses were performed using SigmaStat ver-
sion 3.1.1 software (Jandel Scientific, San Rafael, CA).
Data are given as the mean ± SEM. Comparison of the
differences between the means for each treatment was
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Results
Testis and epididymidis weight and sperm quality
parameters
It has been reported elsewhere that a single dose of
busulfan can permanently sterilize mice at nonlethal
doses [10]. We have previously demonstrated that CD-1
mice treated with two doses of 40 mg/kg of busulfan
remain sterile 70 days after the administration of the
drug.
No significant differences were observed between the
LGF and control groups in terms of either testis and
epididymis weight (Figure 1) or sperm motility and con-
centration (Figure 2), indicating that LGF treatment did
not induce either an increase in testis and epididymidis
weight or an improvement in sperm quality in a normal
testis. As observed by other authors [10], mice analyzed
70-63 days after the administration of the first-second
doses of 40 mg/kg busulfan showed both a decrease in
testis and epididymidis weight and a decrease in sperm
concentration and motility when compared with the
control and the LGF group (Figures 1 and 2).
When animals treated with busulfan were injected with
LGF, there was a decrease in the parameters analyzed
compared to the control and LGF groups. However, testis
and epididymidis weight and sperm concentration were
significantly higher than the values observed in animals
treated with busulfan alone. Sperm motility in the ani-
mals treated with busulfan and LGF was different from
the value observed in mice treated with busulfan alone;
this value was also lower than that observed in the con-
trol and in the LGF groups (Figure 2).
Histological study
Histological analysis of testes from animals of the con-
trol group is represented in Figure 3A. Histological ana-
lysis of testes 63 days after busulfan treatment showed a
reduction in the diameter of the seminiferous tubules
and several morphological abnormalities such as germ
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Figure 1 Differences in testis and epididymis weight observed
between experimental groups. Epididymal (A) and testicular
(B) weight in the four groups of animals analyzed (control, LGF
treatment, busulfan treatment, busulfan plus LGF treatment).
a, b,
cDifferent letters indicate significant differences between groups
based on one-way ANOVA (P ≤ 0.01). Error bars, SEM. LGF: liver
growth factor.
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Figure 2 Differences in sperm motility and concentration
observed between experimental groups. Spermatozoal
concentration (×10
6 sperm per ml) (A) and motility (B) in sperm
samples recovered from cauda epididymidis and vasa deferentia of
the four groups of males analyzed (control, LGF treatment, busulfan
treatment, busulfan plus LGF treatment).
a, b, cDifferent letters
indicate significant differences between groups based on one-way
ANOVA (P ≤ 0.01). Error bars, SEM. LGF: liver growth factor.
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Page 3 of 5cell sloughing, tubule plugging, vacuolization and Sertoli
cell-only tubules (Figure 3 and 4). In the interstitium,
areas with nodules of hyperplastic Leydig cells were also
observed (Figure 3B). In the group treated with busulfan
and LGF, a recovery of germ cells was detected in most
of the tubules, although some of them showed disrup-
tion of the germinal epithelium (Figure 3C). The hyper-
plasia of Leydig cells was still observed, but it was not
as evident as that observed in the group treated with
busulfan alone.
Discussion
In this study, we show that LGF treatment in control
mice has no effect on either testicular and epididymal
weight or on sperm quality. However, LGF treatment
applied to animals that have been subjected to testicular
damage involving the germinal epithelium seems to
induce a regeneration of the testis that is reflected in an
increase in the weight of testis and epididymis. It also
seems that LGF treatment in busulfan-treated animals
that have suffered a disruption of spermatogenesis can
accelerate the reactivation of this process in most of the
tubules, as shown in the histological analysis. This reac-
tivation is also demonstrated by the increase in the
sperm concentration value compared to that observed in
the animals treated with busulfan alone.
Spermatogenesis is dependent on a population of cells
called spermatogonial stem cells. Their number in the
testis is very small, and is estimated to be about 2-3 ×
10
4 in mice [14]. After busulfan treatment, stem cell
expansion starts immediately and the doubling time for
stem cells is 1-5 weeks [14]. The doses of busulfan used
in this work (40 mg/kg) were previously shown to
achieve complete depletion of germ cells, but only par-
tial depletion of testicular stem cells to allow sponta-
neous recovery to occur [15]. We observed the expected
responses from the busulfan-treated group. Moreover,
LGF affects spermatogenic recovery after injury induced
experimentally by busulfan. The remaining spermatogo-
nial stem cells are capable of inducing spermatogenic
recovery, and we propose that LGF activates these stem
cells to induce a faster recovery of spermatogenesis. As
previous authors have reported [22], the histological
study showed that busulfan treatment apparently did
not affect Sertoli or spermatogonial stem cells, but some
morphological abnormalities of the seminiferous tubules
were noted. The recovery of the normal histological
structure after LGF administration to animals treated
previously with busulfan showed not only a reactivation
of the spermatogenic process, but also the regeneration
of the microenvironment necessary for successful sper-
m a t o g e n e s i s .I tc o u l db ea l s os p e c u l a t e dt h a tL G Fm a y
have a role in normal development of spermatogenesis,
as previously has been reported for the hepatocyte
A
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Figure 3 Histological comparison of seminiferous tubules from
testes of experimental groups. Pictures of the control group (A);
63 days after busulfan treatment (B) with Sertoli cell-only tubules
(sterisk) and nodules of hyperplastic Leydig cells (star); and 63 days
after the injection of busulfan and liver growth factor (C) with
tubules showing vacuolization (arrow). Hematoxylin & eosin. Bar
50 μm.
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Figure 4 Seminiferous tubule diameters from the three groups
of mice analyzed. Control, busulfan treatment, busulfan plus LGF
treatment.
a, b, cDifferent letters indicate significant differences
between groups based on one-way ANOVA (P ≤ 0.01). Error bars,
SEM. LGF: liver growth factor.
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val and proliferation of germ cells during postnatal testis
development [23].
Conclusions
It has been demonstrated that LGF promotes germinal
cell growth in male rat after ethane dimethanesulfonate
(EDS)-induced testicular damage [6]. Here we have
observed that intraperitoneal administration of LGF was
able to restore spermatogenesis in mice sterilized with
busulfan, suggesting that LGF can collaborate in the
mobilization of testicular stem cells to restore spermato-
genesis after germinal epithelium damage. As busulfan
is an anticancer drug that affects fertility, the adminis-
tration of LGF could be employed as a single treatment
to induce the recovery of patients from busulfan
treatment.
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